IP Library Granted Patent US 9,555,017
Granted Patent B2
US 9,555,017 · App. 14/821,384 · Granted Jan 31, 2017

Methods of making a mixture of salts of gamma-hydroxybutyrate

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,555,017
App. No.
14/821,384
Granted
Jan 31, 2017
Kind
B2
Abstract

Provided herein are pharmaceutical compositions and formulations comprising mixed salts of gamma-hydroxybutyrate (GHB). Also provided herein are methods of making the pharmaceutical compositions and formulations, and methods of their use for the treatment of sleep disorders such as apnea, sleep time disturbances, narcolepsy, cataplexy, sleep paralysis, hypnagogic hallucination, sleep arousal, insomnia, and nocturnal myoclonus.

Claims (30)

1. A method of making a mixture of two or more salts of gamma-hydroxybutyrate (GHB), the method comprising:

contacting gamma-butyrolactone (GBL) with two or more bases selected from the group consisting of sodium hydroxide (NaOH), potassium hydroxide (KOH), magnesium hydroxide (Mg(OH) 2 ), and calcium hydroxide (Ca(OH) 2 ), in a single reaction vessel under conditions sufficient to produce a mixture of two or more salts selected from the group consisting of a sodium salt of gamma-hydroxybutyrate (Na.GHB), a potassium salt of gamma-hydroxybutyrate (K.GHB), a magnesium salt of gamma-hydroxybutyrate (Mg.(GHB) 2 ), and a calcium salt of gamma-hydroxybutyrate (Ca.(GHB) 2 ).

2. The method of claim 1 , wherein the GBL is contacted with four bases selected from the group consisting of NaOH, KOH, Mg(OH) 2 , and Ca(OH) 2 .

3. The method of claim 1 , wherein the GBL is contacted with three bases selected from the group consisting of NaOH, KOH, Mg(OH) 2 , and Ca(OH) 2 .

4. The method of claim 3 , wherein the GBL is contacted with KOH, Mg(OH) 2 , and Ca(OH) 2 .

5. The method of claim 1 , wherein the GBL is contacted with two bases selected from the group consisting of KOH, Mg(OH) 2 , and Ca(OH) 2 .

6. The method of claim 1 , wherein the contacting comprises addition of the GBL to the bases.

7. The method of claim 1 , wherein the contacting comprises addition of the bases to the GBL.

8. The method of claim 1 , wherein the conditions sufficient to produce the mixture comprise placing the reaction vessel in a water bath controlled to 80° C. for at least 3 hours.

9. The method of claim 1 , further comprising filtering the mixture.

10. The method of claim 1 , wherein the weighted average molecular weight per molar equivalent of the mixture of salts is about 126.09.

11. The method of claim 1 , further comprising adding one or more of a buffering agent, a sweetening agent, a flavoring agent or a coloring agent, optionally in a pharmaceutically acceptable carrier.

12. A method of making a mixture of two or more salts of GHB, the Method comprising:

contacting GBL with two or more bases selected from the group consisting of NaOH, KOH, Mg(OH) 2 , and Ca(OH) 2 , in two reaction vessels under conditions sufficient to produce a mixture of two or more salts selected from the group consisting of Na.GHB, K.GHB, Mg.(GHB) 2 , and Ca.(GHB) 2 ;

wherein the GBL is contacted with Mg(OH) 2 in the first reaction vessel, and

wherein the GBL is contacted with one or more of NaOH, KOH, and Ca(OH) 2 in the second reaction vessel.

13. The method of claim 12 , wherein the mixture comprises Mg.(GHB) 2 and Ca.(GHB) 2 .

14. The method of claim 12 , wherein the GBL is contacted with three bases selected from the group consisting of NaOH, KOH, Mg(OH) 2 , and Ca(OH) 2 .

15. The method of claim 14 , wherein the GBL is contacted with KOH, Mg(OH) 2 , and Ca(OH) 2 .

16. The method of claim 12 , wherein the contacting comprises addition of the GBL to the bases.

17. The method of claim 12 , wherein the contacting comprises addition of the bases to the GBL.

18. A method of making a mixture of four salts of GHB, the method comprising:

contacting GBL with four bases selected from the group consisting of NaOH, KOH, Mg(OH) 2 , and Ca(OH) 2 , in a single reaction vessel under conditions sufficient to produce a mixture of four salts selected from the group consisting of Na.GHB, K.GHB, Mg.(GHB) 2 , and Ca.(GHB) 2 .

19. The method of claim 18 , wherein the contacting comprises addition of the GBL to the bases.

20. The method of claim 18 , wherein the contacting comprises addition of the bases to the GBL.

21. The method of claim 18 , wherein the conditions sufficient to produce the mixture comprise placing the reaction vessel in a water bath controlled to 80° C. for at least 3 hours.

22. The method of claim 18 , further comprising filtering the mixture.

23. The method of claim 18 , wherein the reaction vessel having has at least a one liter capacity.

24. The method of claim 18 , wherein the weighted average molecular weight per molar equivalent of the mixture of salts is about 126.09.

25. The method of claim 18 , further comprising adding one or more of a buffering agent, a sweetening agent, a flavoring agent or a coloring agent, optionally in a pharmaceutically acceptable carrier.

Assignments (3)
SECURITY AGREEMENT Recorded May 5, 2021
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056151/0010 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2020
From: ALLPHIN, CLARK P.; DESJARDIN, MICHAEL
To: JAZZ PHARMACEUTICALS, INC.
Reel/Frame 052805/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2020
From: JAZZ PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 052805/0249 →